{
    "title": "Amgen 1st quarter profit falls as costs rise, sales up 2%",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-12022811/Amgen-1st-quarter-profit-falls-costs-rise-sales-2.html",
    "date": "2023-04-27",
    "keywords": [
        "amgen",
        "revenue",
        "year",
        "drug",
        "horizon",
        "deal",
        "beasley",
        "quarter",
        "company",
        "enbrel",
        "analyst",
        "research",
        "note",
        "tax",
        "inc",
        "thursday",
        "firstquarter",
        "profit",
        "increase",
        "covid19",
        "antibody",
        "product",
        "volume",
        "selling",
        "exchange",
        "share",
        "prescription",
        "demand",
        "executive",
        "robert",
        "bradway",
        "conference",
        "call",
        "trading",
        "repatha",
        "record",
        "aimovig",
        "otezla",
        "drop",
        "part",
        "net",
        "core",
        "confidence",
        "capital",
        "seigerman",
        "operating",
        "development",
        "rate",
        "percentage",
        "puerto",
        "rico",
        "law",
        "change",
        "biotechnology",
        "forecast",
        "view",
        "impact",
        "acquisition",
        "end",
        "june",
        "focus",
        "growth",
        "michael",
        "portfolio",
        "access",
        "eye",
        "disease",
        "treatment",
        "tepezza",
        "reporting",
        "deena",
        "bill",
        "berkrot"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}